Topics

GlaxoSmithKline buys Sitari Pharmaceuticals, gaining coeliac disease programme https://www.firstwordpharma.com/node/1665491  $GSK

06:59 EDT 11 Sep 2019 | FirstWord Pharma

GlaxoSmithKline buys Sitari Pharmaceuticals, gaining coeliac disease programme https://www.firstwordpharma.com/node/1665491 

Original Article: GlaxoSmithKline buys Sitari Pharmaceuticals, gaining coeliac disease programme https://www.firstwordpharma.com/node/1665491  $GSK

NEXT ARTICLE

More From BioPortfolio on "GlaxoSmithKline buys Sitari Pharmaceuticals, gaining coeliac disease programme https://www.firstwordpharma.com/node/1665491  $GSK"

Quick Search

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...